Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-024955

Chief Medical Officer bought 1,508 shares at $32.96 ($49,704)

From the SEC's structured data for this filing

Trades in this filing

Patel Naimish · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-04-03 Purchase : show line 1 in the form +1,508 $32.96 $49,704 1,508 D
Open-market purchases · 1,508 sh · avg $32.96 · $49,704
Loading xslF345X05/ownership.xml…